| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10K | — | +47.9% |
| R&D Expense | $184K | +36.6% | +66.5% |
| SG&A Expense | $76K | -20.2% | -24.8% |
| Operating Income | -$644K | -6.5% | +12.3% |
| Net Income | -$680K | -5.6% | +11.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $30K | +163.5% | -93.4% |
| Total Assets | $272K | +21.5% | -60.7% |
| Current Liabilities | $3.5M | +8.9% | +19.8% |
| Total Liabilities | $3.6M | +9.6% | +19.5% |
| Stockholders' Equity | -$3.3M | -8.7% | -43.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.5M | — | — |
| Financing Cash Flow | $1.5M | — | — |